1. Tsung, K., Meko, J.B., Peplinski, G.R., Tsung, Y.L. & Norton, J.A. IL-12 induces T helper 1–directed antitumor response. J. Immunol. 158, 3359–3365 (1997).
2. Brunda, M.J. et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors, J. Exp. Med. 178, 1223–1230 (1993).
3. Rodolfo, M. & Colombo, M.P. Interleukin-12 as an adjuvant for cancer immunotherapy. Methods 19, 114–120 (1999).
4. Nastala, C.L. et al. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697–1706 (1994).
5. Atkins, M.B. et al. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res. 3, 409–417 (1997).